Tandem Diabetes Care (NSDQ:TNDM) and Dexcom (NSDQ:DXCM) announced yesterday that the companies would extend their existing joint welcome program aimed at luring Animas customers as Johnson & Johnson (NYSE:JNJ) bails out of the insulin pump biz. Tandem and Dexcom’s t:slim X2 welcome program was slated to end on Dec. 31, but the companies said yesterday that it would continue until the […]
Animas
Layoffs ahead for nearly 300 as J&J winds down Animas
Johnson & Johnson (NYSE:JNJ) plans to lay off nearly 300 workers in Pennsylvania as it winds down its Animas insulin pump business. The layoffs for 297 are slated for Animas operations in West Chester and Wayne, Pa., effective Dec. 15, according to a notice filed with the Commonwealth’s Dept. of Labor & Industry. J&J announced the shutdown earlier this month […]
Insulet looks to lure Animas users
Just days after Johnson & Johnson (NYSE:JNJ) revealed that it plans to shut down its 410-worker Animas insulin pump subsidiary, Insulet (NSDQ:PODD) said it would offer existing Animas insulin pump users a free trial of the company’s Omnipod system. Insulet’s Welcome Program includes a free Omnipod tubeless insulin delivery system, built-in blood glucose meter and 30 days of supplies […]
Johnson & Johnson to shutter Animas insulin pump biz
Johnson & Johnson (NYSE:JNJ) said today that it plans to shut down its 410-worker Animas insulin pump subsidiary, offering to help some 90,000 Animas patients transfer to products made by rival Medtronic (NYSE:MDT). The Chesterbrook, Pa.-based company said it will stop making its Animas Vibe and OneTouch Ping pumps, but will continue to provide customer service, training and […]
Artificial pancreas: These companies are racing to make one
Medical device companies are close to achieving the holy grail of diabetes treatment: a combined glucose sensor, control algorithm and insulin infusion device that effectively acts as an “artificial pancreas.” We explain more in the newest video from editors at MassDevice’s sister publication Medical Design & Outsourcing. (And for a deeper dive, check out our recent […]
J&J’s Animas wins FDA, Health Canada nod for OneTouch Vibe Plus insulin pump & CGM
Johnson & Johnson‘s (NYSE:JNJ) Animas Corporation subsidiary said today it won FDA approval and Health Canada authorization for its OneTouch Vibe Plus insulin pump and continuous glucose monitoring system. The OneTouch Vibe Plus features integration with Dexcom‘s (NSDQ:DXCM) G5 mobile CGM, and is designed for diabetes patients age 2 and older, the company said. System […]
FDA approves J&J’s Animas Vibe insulin pump & CGM for kids
Johnson & Johnson‘s (NYSE:JNJ) Animas Corporation subsidiary said today the FDA approved its Animas Vibe insulin pump and continuous glucose monitoring system for children and adolescents ages 2 to 17. The Animas Vibe system works with integrated Dexcom Inc. (NSDQ:DXCM) G4 platinum CMG technology and is the only system cleared for patients as young as […]
Neuromod gains CE Mark approval for tinnitus device | Regulatory news for the week of December 1, 2014
Diabetes: FDA approves Animas Vibe with DexCom’s G4 Platinum CGM
Diabetes: J&J units join Joslin tech transfer project
